Iris Acquisition Corp (IRAA)

NASDAQ: IRAA · IEX Real-Time Price · USD
11.50
+0.29 (2.59%)
Jul 2, 2024, 10:29 AM EDT - Market closed
Market Cap 82.65M
Revenue (ttm) n/a
Net Income (ttm) 5.78M
Shares Out 7.19M
EPS (ttm) 0.11
PE Ratio 104.55
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 701
Open 12.05
Previous Close 11.21
Day's Range 11.50 - 12.05
52-Week Range 10.14 - 12.49
Beta 0.11
Analysts n/a
Price Target n/a
Earnings Date Jan 6, 2023

About IRAA

Iris Acquisition Corp does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as Tribe Capital Growth Corp I and changed its name to Iris Acquisition Corp in July 2022. The company was incorporated in 2020 and is based in George Town, Cayman Islands. Iris Acquisition Corp is a subsidiary of Iris Acquisition Holdings LLC. [Read more]

Industry Shell Companies
Sector Financials
IPO Date Mar 5, 2021
Employees 3
Stock Exchange NASDAQ
Ticker Symbol IRAA
Full Company Profile

Financial Performance

Financial Statements

News

Liminatus Pharma LLC and Iris Acquisition Corp to combine to incorporate and accelerate much-needed cancer treatments

NEW YORK & LONDON--(BUSINESS WIRE)--Liminatus Pharma LLC (“Liminatus”), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies and Iris Acquisition Corp (“Ir...

1 year ago - Business Wire